Your browser doesn't support javascript.
loading
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells.
Kolluri, Krishna Kalyan; Alifrangis, Constantine; Kumar, Neelam; Ishii, Yuki; Price, Stacey; Michaut, Magali; Williams, Steven; Barthorpe, Syd; Lightfoot, Howard; Busacca, Sara; Sharkey, Annabel; Yuan, Zhenqiang; Sage, Elizabeth K; Vallath, Sabarinath; Le Quesne, John; Tice, David A; Alrifai, Doraid; von Karstedt, Sylvia; Montinaro, Antonella; Guppy, Naomi; Waller, David A; Nakas, Apostolos; Good, Robert; Holmes, Alan; Walczak, Henning; Fennell, Dean A; Garnett, Mathew; Iorio, Francesco; Wessels, Lodewyk; McDermott, Ultan; Janes, Samuel M.
Afiliação
  • Kolluri KK; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
  • Alifrangis C; Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Kumar N; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
  • Ishii Y; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
  • Price S; Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Michaut M; The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Williams S; Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Barthorpe S; Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Lightfoot H; Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Busacca S; CRUK Leicester Centre, Department of Cancer studies, University of Leicester, Leicester, United Kingdom.
  • Sharkey A; CRUK Leicester Centre, Department of Cancer studies, University of Leicester, Leicester, United Kingdom.
  • Yuan Z; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
  • Sage EK; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
  • Vallath S; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
  • Le Quesne J; CRUK Leicester Centre, Department of Cancer studies, University of Leicester, Leicester, United Kingdom.
  • Tice DA; Oncology Research, MedImmune, Inc., Gaithersburg, United States.
  • Alrifai D; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
  • von Karstedt S; Centre for Cell Death, Cancer and Inflammation, UCL Cancer Institute, University College London, London, United Kingdom.
  • Montinaro A; Centre for Cell Death, Cancer and Inflammation, UCL Cancer Institute, University College London, London, United Kingdom.
  • Guppy N; UCL Advanced Diagnostics, University College London, London, United Kingdom.
  • Waller DA; Department of Thoracic Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, United Kingdom.
  • Nakas A; Department of Thoracic Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, United Kingdom.
  • Good R; UCL School of Pharmacy, University College London, London, United Kingdom.
  • Holmes A; UCL School of Pharmacy, University College London, London, United Kingdom.
  • Walczak H; Centre for Cell Death, Cancer and Inflammation, UCL Cancer Institute, University College London, London, United Kingdom.
  • Fennell DA; CRUK Leicester Centre, Department of Cancer studies, University of Leicester, Leicester, United Kingdom.
  • Garnett M; Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Iorio F; European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, United Kingdom.
  • Wessels L; The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • McDermott U; Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Elife ; 72018 01 18.
Article em En | MEDLINE | ID: mdl-29345617
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Proteínas Supressoras de Tumor / Ubiquitina Tiolesterase / Ligante Indutor de Apoptose Relacionado a TNF / Neoplasias Pulmonares / Mesotelioma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Elife Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Proteínas Supressoras de Tumor / Ubiquitina Tiolesterase / Ligante Indutor de Apoptose Relacionado a TNF / Neoplasias Pulmonares / Mesotelioma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Elife Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido